Allergy Relief
- Product NDC
- 84324-001
- 11-digit product format
- 843240001
- Labeler code
- 84324
- Product ID
- 84324-001_259d4274-1a91-4c14-8e80-874b2c44ab62
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Cetirizine HCl
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NUVICARE LLC
- Application
- ANDA077829
- Marketing category
- ANDA
- Marketing start
- 2024-07-17
- Substance
- CETIRIZINE HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Allergy Relief
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CETIRIZINE HYDROCHLORIDE | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 64O047KTOA |
| Rxcui | 1014678 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 84324-001-01 | Allergy Relief | 100 in 1 BOTTLE | TABLET | 100 | | 2 |
| 84324-001-02 | Allergy Relief | 14 in 1 BLISTER PACK | TABLET | 14 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 84324-001 | ALLERGY RELIEF (CETIRIZINE HCL) TABLET [NUVICARE LLC] | 1 | Current NDC, 1 package rows | 20240717_c728edf3-e6b5-4860-b966-39cf3ee4ff77.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 84324-001-01 | 84324000101 | 100 TABLET in 1 BOTTLE (84324-001-01) | 100 tablet | 2024-07-17 | No | No | Current |
| 84324-001-02 | 84324000102 | 14 TABLET in 1 BLISTER PACK (84324-001-02) | 14 tablet | 2025-06-09 | No | No | Current |